Standard
A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. / Luo, Yunyun; He, Y; Byrjalsen, I; Henriksen, K; Gudmann, N S; Mobasheri, A; Hansen, G; Karsdala, M; Bay-Jensen, A-C.
In:
Osteoarthritis and Cartilage, Vol. 25, No. Suplement 1, 2017, p. S106-S107.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Luo, Y, He, Y, Byrjalsen, I, Henriksen, K, Gudmann, NS, Mobasheri, A, Hansen, G, Karsdala, M & Bay-Jensen, A-C 2017, 'A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH', Osteoarthritis and Cartilage, vol. 25, no. Suplement 1, pp. S106-S107.
APA
Luo, Y., He, Y., Byrjalsen, I., Henriksen, K., Gudmann, N. S., Mobasheri, A., Hansen, G., Karsdala, M., & Bay-Jensen, A-C. (2017). A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. Osteoarthritis and Cartilage, 25(Suplement 1), S106-S107.
Vancouver
Luo Y, He Y, Byrjalsen I, Henriksen K, Gudmann NS, Mobasheri A et al. A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. Osteoarthritis and Cartilage. 2017;25(Suplement 1):S106-S107.
Author
Luo, Yunyun ; He, Y ; Byrjalsen, I ; Henriksen, K ; Gudmann, N S ; Mobasheri, A ; Hansen, G ; Karsdala, M ; Bay-Jensen, A-C. / A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. In: Osteoarthritis and Cartilage. 2017 ; Vol. 25, No. Suplement 1. pp. S106-S107.
Bibtex
@article{54e84d1d6a26407b804c383575aee8fc,
title = "A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH",
keywords = "Faculty of Health and Medical Sciences",
author = "Yunyun Luo and Y He and I Byrjalsen and K Henriksen and Gudmann, {N S} and A Mobasheri and G Hansen and M Karsdala and A-C Bay-Jensen",
year = "2017",
language = "English",
volume = "25",
pages = "S106--S107",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "Elsevier",
number = "Suplement 1",
note = "2017 Osteoarthritis Research Society International (OARSI) World Congress, OARSI ; Conference date: 27-04-2017 Through 30-04-2017",
url = "http://2017.oarsi.org/",
}
RIS
TY - ABST
T1 - A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH
AU - Luo, Yunyun
AU - He, Y
AU - Byrjalsen, I
AU - Henriksen, K
AU - Gudmann, N S
AU - Mobasheri, A
AU - Hansen, G
AU - Karsdala, M
AU - Bay-Jensen, A-C
PY - 2017
Y1 - 2017
KW - Faculty of Health and Medical Sciences
M3 - Conference abstract in journal
VL - 25
SP - S106-S107
JO - Osteoarthritis and Cartilage
JF - Osteoarthritis and Cartilage
SN - 1063-4584
IS - Suplement 1
T2 - 2017 Osteoarthritis Research Society International (OARSI) World Congress
Y2 - 27 April 2017 through 30 April 2017
ER -
